Global Med Technologies(R) to Present at Rodman & Renshaw 10th Annual Healthcare Conference in New York on November 10, 2008
October 20 2008 - 9:00AM
PR Newswire (US)
DENVER, Oct. 20 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. ("Global Med") (OTC:GLOB) (BULLETIN BOARD:
GLOB) , an international e-Health, medical information technology
company, will be presenting at the Rodman & Renshaw 10th Annual
Healthcare Conference to be held November 10-12, 2008, at the New
York Palace Hotel in New York City. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) On
Monday, November 10, at 2:50 p.m. EST, Dr. Mick Ruxin, Chief
Executive Officer of Global Med Technologies, will give a 20-minute
presentation in the Holmes I Room (4th floor), regarding Global
Med's business, unique value proposition, latest developments,
financial performance and future prospects. Management will also
participate in a 10-minute question and answer session following
the presentation and in one-on-one meetings throughout the day.
Last year's Rodman & Renshaw Healthcare Conference included
over 350 presenting companies and over 2,500 attendees, as well as
attendance of experts from the medical, scientific and investment
communities. The categories of presentation include autoimmune
diseases, cardiovascular diseases, CNS, drug delivery, gene
therapy, infectious diseases, medical devices, oncology, specialty
pharmaceuticals, and therapeutic vaccines. A vast number of
institutional investors, venture capitalists, private investors,
industry executives, scientists and other industry leaders are
expected to attend this year's healthcare conference. About Global
Med Technologies, Inc. Global Med Technologies(R), Inc. is an
international medical software company which develops regulated and
non-regulated software products and services for the healthcare
industry. As a leading provider of blood and laboratory software
applications and services, Global Med's products are deployed in 20
countries and serve over 1,600 transfusion centers, blood banks and
laboratories. Global Med's U.S. division, Wyndgate Technologies(R),
provides Vein-to-Vein(R) tracking through its Donor Doc(TM),
SafeTrace(R), SafeTrace Tx(R) and ElDorado Donor(TM) software
products. Each year, Wyndgate's products and services manage more
than eight million blood components, representing over 27% of the
U.S. blood supply. Global Med's European subsidiary, Inlog, SA, is
a leading provider of donor center and transfusion management
systems as well as cellular therapy software, laboratory
information systems and quality assurance medical software systems
internationally. Inlog's products include EdgeBlood*, EdgeTrack*,
EdgeCell, EdgeLab and SAPANET. Global Med's U.S. division,
eDonor(R), provides a web-based donor relationship management
system that integrates recruitment, scheduling, retention and
fulfillment for national as well as local community blood centers
and hospitals. eDonor's products and services are designed to
complement Global Med's strong line of international blood
management and laboratory information software and service
solutions. Global Med's U.S. subsidiary, PeopleMed(R), Inc.,
provides cost-effective customized software validation, consulting
and compliance solutions to hospitals and donor centers. For more
information about Global Med's products and services, please call
800-996-3428 or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/, http://www.inlog.com/,
http://www.edonor.com/, and http://www.wyndgate.com/. *FDA 510(k)
clearance required prior to sales in the U.S. This news release may
include statements that constitute forward-looking statements,
usually containing the words "believe," "estimate," "project,"
"expects" or similar expressions. These statements are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements
inherently involve risks and uncertainties that could cause actual
results to differ materially from the forward-looking statements.
By making these forward-looking statements, the Company undertakes
no obligation to update these statements for revisions or changes
after the date of this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000, ; or Investors, Paul Holm, President of
portfolio pr, +1-212-888-4570, , for Global Med Technologies, Inc.
Web Site: http://www.edonor.com/ http://www.globalmedtech.com/
http://www.inlog.com/ http://www.peoplemed.com/
http://www.wyndgate.com/
Copyright